<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To evaluate the contribution of single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography (SPECT) to the differential diagnosis of <z:hpo ids='HP_0000726'>dementia</z:hpo>, we studied 48 consecutive patients (median age: 63) with a degenerative or vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, a 99mTc-HMPAO SPECT imaging, and a diagnostic confirmation (autopsy or genetic mutation) </plain></SENT>
<SENT sid="1" pm="."><plain>The SPECT scans were visually rated by two nuclear medicine physicians (first blinded to the clinical data, then with the data) </plain></SENT>
<SENT sid="2" pm="."><plain>Comparisons between clinical diagnoses and/or SPECT imaging and neuropathology were performed </plain></SENT>
<SENT sid="3" pm="."><plain>At the time of SPECT was performed, the clinical diagnosis of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) sensitivity was 83%, specificity was 76%, and diagnostic accuracy was 79% </plain></SENT>
<SENT sid="4" pm="."><plain>The blinded SPECT sensitivity was 57%, specificity 92%, and diagnostic accuracy 75% </plain></SENT>
<SENT sid="5" pm="."><plain>The SPECT associated with clinical data sensitivity was 65%, specificity 84%, and accuracy 75% </plain></SENT>
<SENT sid="6" pm="."><plain>The clinical diagnosis of <z:e sem="disease" ids="C0751072" disease_type="Mental or Behavioral Dysfunction" abbrv="FTLD">frontotemporal-lobar degeneration</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>), <z:e sem="disease" ids="C0038868" disease_type="Disease or Syndrome" abbrv="PSNP1">progressive supranuclear palsy</z:e> (PSP), and <z:e sem="disease" ids="C0393570" disease_type="Disease or Syndrome" abbrv="">corticobasal degeneration</z:e> syndrome (CBDs) sensitivity was 83%, specificity 87%, and accuracy 85% </plain></SENT>
<SENT sid="7" pm="."><plain>The blinded SPECT sensitivity was 50%, specificity 97%, and accuracy 79% </plain></SENT>
<SENT sid="8" pm="."><plain>The SPECT associated with clinical data sensitivity was 61%, specificity was 93%, and accuracy 81% </plain></SENT>
<SENT sid="9" pm="."><plain>Whenever the blinded SPECT interpretation agreed with the clinical diagnosis of AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>/PSP/CBDs, the condition was confirmed by neuropathological assessment in <z:hpo ids='HP_0000001'>all</z:hpo> cases </plain></SENT>
<SENT sid="10" pm="."><plain>Compared with clinical diagnosis alone, SPECT imaging improved the specificity of the etiological diagnosis in degenerative <z:hpo ids='HP_0000726'>dementia</z:hpo>, although its sensitivity was not as good as that of clinical diagnosis </plain></SENT>
<SENT sid="11" pm="."><plain>For AD and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">FTLD</z:e>/PSP/CBDs, agreement between the clinical and SPECT-based diagnoses was always confirmed by neuropathological assessment </plain></SENT>
</text></document>